⚽   Catch the 2026 World Cup Fever!   ⚽
Logo
Loading Weather...

Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress

Business June 25, 2026 0 Views
Legend Biotech Corporation (LEGN) Price Target Raised to $49 on LB5006 Clinical Progress
Source: https://finance.yahoo.com/rss/topstories - Read Original

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!